315 related articles for article (PubMed ID: 26497530)
1. Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity.
van Egmond M; Vidarsson G; Bakema JE
Immunol Rev; 2015 Nov; 268(1):311-27. PubMed ID: 26497530
[TBL] [Abstract][Full Text] [Related]
2. Antibody-opsonized bacteria evoke an inflammatory dendritic cell phenotype and polyfunctional Th cells by cross-talk between TLRs and FcRs.
Bakema JE; Tuk CW; van Vliet SJ; Bruijns SC; Vos JB; Letsiou S; Dijkstra CD; van Kooyk Y; Brenkman AB; van Egmond M
J Immunol; 2015 Feb; 194(4):1856-66. PubMed ID: 25582855
[TBL] [Abstract][Full Text] [Related]
3. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
Tartey S; Takeuchi O
Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
[TBL] [Abstract][Full Text] [Related]
4. Fc receptor inside-out signaling and possible impact on antibody therapy.
Brandsma AM; Jacobino SR; Meyer S; ten Broeke T; Leusen JH
Immunol Rev; 2015 Nov; 268(1):74-87. PubMed ID: 26497514
[TBL] [Abstract][Full Text] [Related]
5. FcγRIIa cross-talk with TLRs, IL-1R, and IFNγR selectively modulates cytokine production in human myeloid cells.
Vogelpoel LT; Hansen IS; Visser MW; Nagelkerke SQ; Kuijpers TW; Kapsenberg ML; de Jong EC; den Dunnen J
Immunobiology; 2015 Feb; 220(2):193-9. PubMed ID: 25108563
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways downstream of pattern-recognition receptors and their cross talk.
Lee MS; Kim YJ
Annu Rev Biochem; 2007; 76():447-80. PubMed ID: 17328678
[TBL] [Abstract][Full Text] [Related]
7. Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.
Ben Mkaddem S; Benhamou M; Monteiro RC
Front Immunol; 2019; 10():811. PubMed ID: 31057544
[TBL] [Abstract][Full Text] [Related]
8. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors: promising therapeutic targets for inflammatory diseases.
Achek A; Yesudhas D; Choi S
Arch Pharm Res; 2016 Aug; 39(8):1032-49. PubMed ID: 27515048
[TBL] [Abstract][Full Text] [Related]
10. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors in human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulins and their receptors, and subversion of their protective roles by bacterial pathogens.
Woof JM
Biochem Soc Trans; 2016 Dec; 44(6):1651-1658. PubMed ID: 27913674
[TBL] [Abstract][Full Text] [Related]
13. Human antibody-Fc receptor interactions illuminated by crystal structures.
Woof JM; Burton DR
Nat Rev Immunol; 2004 Feb; 4(2):89-99. PubMed ID: 15040582
[TBL] [Abstract][Full Text] [Related]
14. Fc-receptors as regulators of immunity.
Nimmerjahn F; Ravetch JV
Adv Immunol; 2007; 96():179-204. PubMed ID: 17981207
[TBL] [Abstract][Full Text] [Related]
15. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors and innate immunity.
Kumar H; Kawai T; Akira S
Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor signaling in parasitic infections.
Ashour DS
Expert Rev Clin Immunol; 2015 Jun; 11(6):771-80. PubMed ID: 25896399
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in the development of Toll-like receptor (TLR) antagonists.
Patra MC; Choi S
Expert Opin Ther Pat; 2016 Jun; 26(6):719-30. PubMed ID: 27136061
[TBL] [Abstract][Full Text] [Related]
19. More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation.
Hajishengallis G; Lambris JD
Immunol Rev; 2016 Nov; 274(1):233-244. PubMed ID: 27782328
[TBL] [Abstract][Full Text] [Related]
20. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
